TXNIP and diabetic cardiomyopathy: Hyperglycemia increases Thioredoxin-interacting protein (TXNIP) levels and elevated TXNIP levels are markers of glucotoxicity effects including reduced skeletal muscle and cardiac glucose uptake, diabetic cardiomyopathy, and impaired β-cell function27–31.